Apr 15, 2025 | National
A congressional hearing meant to address the Food and Drug Administration’s (FDA) handling of non-psychoactive CBD turned into a discussion about intoxicating hemp products and health fears – and reflecting the ongoing power struggle between the hemp and marijuana...
Apr 13, 2025 | National
President Donald Trump has chosen conservative journalist Sara Carter to serve as the director of the White House Office of National Drug Control Policy. Carter is a former Fox News contributor with no formal drug policy, public health, or law enforcement...
Apr 13, 2025 | National
The US Food and Drug Administration (FDA) was dragged through the mud by lawmakers yesterday, who said its ‘bureaucratic red tape, inefficiencies, and weak oversight’ was responsible for the flood of intoxicating hemp substances across the country. The US House...
Apr 9, 2025 | National
Marijuana rescheduling is not a part of President Donald Trump’s drug policy priorities for the first year of his second term, according to the White House. Instead, the initial six priorities will largely focus on combating drug trafficking and mitigating the opioid...
Apr 9, 2025 | National
Another week, another move from an established company into the federally legal, hemp-derived THC market. Organigram Global, one of Canada’s largest marijuana producers, announced April 1 that it was entering the growing delta-9 beverage segment through...
Apr 2, 2025 | National
President Donald Trump’s choice to serve as the next White House drug czar has called medical marijuana a “fantastic” treatment option for seriously ill patients and said she doesn’t have a “problem” with legalization, even if she might not personally agree with the...
